Nearly 200,000 men in the United States have been diagnosed with prostate cancer, making it the most common form of cancer among American men today. For many, the condition will leave them unable to work and struggling to secure a resource for income. While prostate cancer may qualify sufferers for Social Security Disability benefits, the process of securing an approval for cancer disability claims can be difficult.
A social security disability claim can become bogged down for many reasons, but one of the most common is a lack of adequate documentation surrounding a claimant’s condition and treatment. To combat this issue, the Social Security Administration recently added prostate cancer to a list of conditions called Compassionate Allowances that can receive expedited processing through the disability system. The move allows those suffering from prostate cancer to receive faster access to benefits, which can be crucial considering for patients who are terminally ill.
According to The Houston Chronicle, the most recent numbers show the compassionate allowances program is a success, as more than 200,000 disabled workers have had their claims processed through the new system successfully.
The Social Security disability lawyers at Fleschner, Stark, Tanoos & Newlin applaud the move to add prostate cancer to the list of Compassionate Allowances. The firm would also encourage anyone considering applying for Social Security Disability or who has a claim that was denied in the past to speak with an attorney to see if their condition has been added to the list as well.
Fleschner, Stark, Tanoos & NewlinN/a
The financial burden that often comes with a serious injury can be too much for many people to bear. Unexpected medical debt, damaged personal property, and the sudden loss of income can impact the budgets of most families. The good news is that a successful injury claim could help reduce that financial strain after a serious accident. Get in touch with a Terre Haute personal injury lawyer with Fleschner, Stark, Tanoos & Newlin to learn more.
© Fleschner, Stark, Tanoos & Newlin